Jon Congleton
Chief Executive Officer at Mineralys Therapeutics. Based in Radnor, Pennsylvania.
- Rank
- 10801st of 14,644
- Companies held
- 1
- Largest holding
- MLYS, 100.0% of total
- Latest SEC filing
- Sep 30, 2026
What the $7.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Mineralys Therapeutics MLYS Common Stock | Directly | 528,621 | $14.31 | $7.6M | 100.0% | Form 4, Sep 30, 2026 |
Share counts are the amounts Jon Congleton reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Sold | MLYS | 75,000 | $25.46 | $1.9M | View |
| Jul 13, 2026 | Sold | MLYS | 10,700 | $27.24 | $291K | View |
| Jun 30, 2026 | Sold | MLYS | 17,000 | $26.82 | $456K | View |
| Jun 30, 2026 | Sold | MLYS | 58,000 | $25.94 | $1.5M | View |
| Apr 13, 2026 | Sold | MLYS | 15,730 | $26.83 | $422K | View |
| Mar 31, 2026 | Sold | MLYS | 19,364 | $25.50 | $494K | View |
| Mar 31, 2026 | Sold | MLYS | 453 | $27.05 | $12K | View |
| Mar 31, 2026 | Sold | MLYS | 55,183 | $26.54 | $1.5M | View |
| Jan 12, 2026 | Sold | MLYS | 9,119 | $32.21 | $294K | View |
| Jan 12, 2026 | Sold | MLYS | 7,117 | $33.15 | $236K | View |
| Nov 11, 2025 | Sold | MLYS | 32,850 | $46.89 | $1.5M | View |
| Nov 11, 2025 | Sold | MLYS | 112,275 | $45.83 | $5.1M | View |
| Nov 11, 2025 | Sold | MLYS | 29,207 | $45.20 | $1.3M | View |
| Nov 11, 2025 | Sold | MLYS | 4,000 | $43.50 | $174K | View |
| Nov 11, 2025 | Sold | MLYS | 8,862 | $42.31 | $375K | View |
| Nov 11, 2025 | Sold | MLYS | 12,806 | $41.64 | $533K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 10798 | Caryl Lyn Hilliard EVP, People and Places, Intuit. Mountain View, CA | $7.6M |
| 10799 | Joshua Horowitz Director, Limbach Holdings. Greenwich, CT | $7.6M |
| 10800 | McCormick, Andrew C Vice President, T. Rowe Price Group. Baltimore, MD | $7.6M |
| 10801 | Jon Congleton Chief Executive Officer, Mineralys Therapeutics. Radnor, PA | $7.6M |
| 10802 | John L. Hennessy Director, Alphabet. Mountain View, CA | $7.6M |
| 10803 | Clive A. Punter EVP and Chief Revenue Officer, OUTFRONT Media. New York, NY | $7.6M |
| 10804 | H. Edward Hanway Director, Marsh & McLennan Companies. New York, NY | $7.6M |
Other Mineralys Therapeutics insiders
All MLYS insiders- Brian Taylor Slingsby$113MDirector. #1372 overall
Questions
How much stock does Jon Congleton own?
Jon Congleton holds $7,561,923 in listed stock based on SEC filings and current prices, mostly Mineralys Therapeutics (MLYS). That ranks 10801st on the Stock Rich List.
Is this Jon Congleton's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Jon Congleton last buy or sell stock?
The most recent open-market trade on file is a sale of 75,000 MLYS shares on Sep 30, 2026 at $25.46.